Page 4 - Nasdaq Proc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Procaps Group (NASDAQ:PROC – Get Rating) and Reviva Pharmaceuticals (NASDAQ:RVPH – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, analyst recommendations and risk. Earnings and Valuation This table compares Procaps Group and […]

Shares of Procaps Group S.A. (NASDAQ:PROC – Get Rating) traded up 8.3% during mid-day trading on Monday . The company traded as high as $4.84 and last traded at $4.84. 370 shares changed hands during trading, a decline of 99% from the average session volume of 35,089 shares. The stock had previously closed at $4.47. […]

Procaps Group S.A. (NASDAQ:PROC – Get Rating)’s share price fell 11% on Tuesday . The stock traded as low as $4.68 and last traded at $4.69. 2,460 shares were traded during mid-day trading, a decline of 93% from the average session volume of 36,094 shares. The stock had previously closed at $5.27. Procaps Group Price […]

MIAMI and BARRANQUILLA, Colo., Dec. 22, 2022 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated...

MIAMI and BARRANQUILLA, Colombia, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and...